Sign in
4

Changes in Ownership

KIORA PHARMACEUTICALS INC Filed Acc 0001144204-18-021207

Chief Commercial Officer bought 156,250 shares

From the SEC's structured data for this filing

Trades in this filing

Garanzini Michael · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-04-17 Purchase : show line 1 in the form +156,250 171,250 D
Open-market purchases · 156,250 sh

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-04-17 Purchase : show line 2 in the form Warrants (right to buy) +156,250 $0.32 2023-04-17 156,250 156,250 D
Loading xslF345X03/tv491364_4.xml…